These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

59 related items for PubMed ID: 16757349

  • 1. Characterization of RERG: an estrogen-regulated tumor suppressor gene.
    Key MD, Andres DA, Der CJ, Repasky GA.
    Methods Enzymol; 2006; 407():513-27. PubMed ID: 16757349
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancer.
    Finlin BS, Gau CL, Murphy GA, Shao H, Kimel T, Seitz RS, Chiu YF, Botstein D, Brown PO, Der CJ, Tamanoi F, Andres DA, Perou CM.
    J Biol Chem; 2001 Nov 09; 276(45):42259-67. PubMed ID: 11533059
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
    de Candia P, Akram M, Benezra R, Brogi E.
    Hum Pathol; 2006 Aug 09; 37(8):1032-41. PubMed ID: 16867866
    [Abstract] [Full Text] [Related]

  • 11. Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach.
    Tozlu S, Girault I, Vacher S, Vendrell J, Andrieu C, Spyratos F, Cohen P, Lidereau R, Bieche I.
    Endocr Relat Cancer; 2006 Dec 09; 13(4):1109-20. PubMed ID: 17158757
    [Abstract] [Full Text] [Related]

  • 12. RERG suppresses cell proliferation, migration and angiogenesis through ERK/NF-κB signaling pathway in nasopharyngeal carcinoma.
    Zhao W, Ma N, Wang S, Mo Y, Zhang Z, Huang G, Midorikawa K, Hiraku Y, Oikawa S, Murata M, Takeuchi K.
    J Exp Clin Cancer Res; 2017 Jun 28; 36(1):88. PubMed ID: 28659184
    [Abstract] [Full Text] [Related]

  • 13. Identification of cyclin D1- and estrogen-regulated genes contributing to breast carcinogenesis and progression.
    Yang C, Trent S, Ionescu-Tiba V, Lan L, Shioda T, Sgroi D, Schmidt EV.
    Cancer Res; 2006 Dec 15; 66(24):11649-58. PubMed ID: 17178859
    [Abstract] [Full Text] [Related]

  • 14. Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer.
    Tabuchi Y, Matsuoka J, Gunduz M, Imada T, Ono R, Ito M, Motoki T, Yamatsuji T, Shirakawa Y, Takaoka M, Haisa M, Tanaka N, Kurebayashi J, Jordan VC, Naomoto Y.
    Int J Oncol; 2009 Feb 15; 34(2):313-9. PubMed ID: 19148464
    [Abstract] [Full Text] [Related]

  • 15. Expression of the RERG gene is gender-dependent in hepatocellular carcinoma and regulated by histone deacetyltransferases.
    Wang AG, Fang W, Han YH, Cho SM, Choi JY, Lee KH, Kim WH, Kim JM, Park MG, Yu DY, Kim NS, Lee DS.
    J Korean Med Sci; 2006 Oct 15; 21(5):891-6. PubMed ID: 17043425
    [Abstract] [Full Text] [Related]

  • 16. Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer.
    Lin CY, Ström A, Li Kong S, Kietz S, Thomsen JS, Tee JB, Vega VB, Miller LD, Smeds J, Bergh J, Gustafsson JA, Liu ET.
    Breast Cancer Res; 2007 Oct 15; 9(2):R25. PubMed ID: 17428314
    [Abstract] [Full Text] [Related]

  • 17. Challenges in projecting clustering results across gene expression-profiling datasets.
    Lusa L, McShane LM, Reid JF, De Cecco L, Ambrogi F, Biganzoli E, Gariboldi M, Pierotti MA.
    J Natl Cancer Inst; 2007 Nov 21; 99(22):1715-23. PubMed ID: 18000217
    [Abstract] [Full Text] [Related]

  • 18. RRIG1 mediates effects of retinoic acid receptor beta2 on tumor cell growth and gene expression through binding to and inhibition of RhoA.
    Liang ZD, Lippman SM, Wu TT, Lotan R, Xu XC.
    Cancer Res; 2006 Jul 15; 66(14):7111-8. PubMed ID: 16849557
    [Abstract] [Full Text] [Related]

  • 19. Re-expression of tumorigenicity after attenuation of human synaptotagmin 13 in a suppressed microcell hybrid cell line.
    Jahn JE, Coleman WB.
    Int J Oncol; 2008 Feb 15; 32(2):441-9. PubMed ID: 18202767
    [Abstract] [Full Text] [Related]

  • 20. Arylamine N-acetyltransferase 1 expression in breast cancer cell lines: a potential marker in estrogen receptor-positive tumors.
    Wakefield L, Robinson J, Long H, Ibbitt JC, Cooke S, Hurst HC, Sim E.
    Genes Chromosomes Cancer; 2008 Feb 15; 47(2):118-26. PubMed ID: 17973251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.